Factory 99% Baloxavir Marboxil CAS 1985606-14-1 Chemical Intermediate Baloxavir Marboxil

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A378
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Baloxavir Marboxil
• CAS: 1985606-14-1
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 100g
• Function: Antiviral
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Baloxavir Marboxil
Appearance	White Powder
CAS NO.	1985606-14-1
Molecular Formula	C27H23F2N3O7S
Storage	Keep in a cool, dry, dark location

 

Baloxavir Marboxil is an antiviral drug that belongs to a new class of medications designed to treat influenza. It is a first-in-class cap-dependent endonuclease inhibitor that specifically targets the endonuclease subunit of the influenza virus polymerase acidic (PA) protein, thereby inhibiting viral replication.

 

 

1. Treatment of Influenza: Baloxavir Marboxil is indicated for the treatment of acute uncomplicated influenza in patients aged 12 years and older who have been symptomatic for no more than 48 hours.
2. High-Risk Populations: It is also approved for use in high-risk populations, such as those with underlying medical conditions or who are at risk of developing complications from influenza, to reduce the duration of symptoms and the risk of influenza-related complications.
3. Alternative to Other Antivirals: Baloxavir Marboxil offers an alternative treatment option to other antiviral medications commonly used for influenza, such as oseltamivir, with potential advantages in terms of dosing frequency and duration of treatment.

1. Inhibition of Viral Replication: By inhibiting the endonuclease activity of the influenza virus PA protein, Baloxavir Marboxil prevents the virus from replicating and spreading within the body.
2. Reduction of Symptom Duration: By inhibiting viral replication, Baloxavir Marboxil helps to reduce the duration and severity of influenza symptoms, allowing patients to recover more quickly.
3. Prevention of Complications: By reducing viral load and inhibiting viral replication, Baloxavir Marboxil may also help to prevent influenza-related complications, such as pneumonia and other respiratory issues, especially in high-risk populations.